Home/MEDICAL CANNABIS AND PARKINSON’S

MEDICAL CANNABIS AND PARKINSON’S

MEDICAL CANNABIS AND PARKINSON’S 2019-04-15T10:57:53+00:00

WHAT’S KNOWN AND WHAT’S NOT

|PRESENTED BY THE CUMMINGS CENTRE AND PARKINSON CANADA

Experts will share their knowledge on medical cannabis use in Parkinson’s care & research. They will provide a balanced overview of what’s known and what’s not and answer your questions on this timely topic.

Cost 40$ includes:

  • Access to the conference,
  • Lunch & refreshments (kosher option available with paid registration),
  • Free parking.

Transportation to and from Cummings if needed with paid registration.

Advance registration is required to guarantee your place at www.parkinson.ca/qcmay1.

|BIOs

LYNDA BALNEAVES

Dr. Lynda Balneaves, PhD, RN, University of Manitoba, Deputy Director of the Canadian Consortium for the Investigation of Cannabinoids (CCIC). Dr. Balneaves will provide an overarching view of the use of medical cannabis in Canada.

SUSAN FOX

Dr. Susan Fox, MD, Associate Director, Movement Disorders Clinic, UHN Toronto, neurologist and movement disorder specialist. Dr. Fox will present a balanced overview of medical cannabis use in Parkinson’s disease and Parkinson’s research.

MICHAEL DWORKIND

Dr. Michael Dworkind, MD, McGill University and the Jewish General Hospital, Medical Director of Santé Cannabis. Dr. Dworkind will describe how different is the effect of cannabis on aging consumers and explain the functioning of a medical cannabis clinic.

EVENT CODE: LCT-307

DATE: Wednesday, May 1, 2019

TIME: 10 AM – 3 PM (Registration 9:30 AM)

LOCATION: Gelber Conference Center, 5151 Ch de la Côte-Sainte-Catherine

LANGUAGE: Bilingual

WHEELCHAIR ACCESS: Yes

PRICE

$40

includes registration and lunch (kosher)

SAVE YOUR SPOT

Contact Stefani Novick by phone at 514-734-1819.

REGISTER NOW